Back to today’s briefing

Story perspectives

Trump's Tariff Threat: Drug Prices and Access at Risk

4/21/2025

36 8

Summary

Story summary

The Trump administration is probing potential tariffs on imported pharmaceuticals, raising alarms over national security. Industry giants like Johnson & Johnson and Eli Lilly caution that such tariffs could inflate drug prices and disrupt vital supply chains, ultimately jeopardizing research and development and limiting patient access to essential medications across the U.S.

1 of 1

Story summary

The Trump administration is probing potential tariffs on imported pharmaceuticals, raising alarms over national security. Industry giants like Johnson & Johnson and Eli Lilly caution that such tariffs could inflate drug prices and disrupt vital supply chains, ultimately jeopardizing research and development and limiting patient access to essential medications across the U.S.